State Trading Organization PLC Pharmaceutical Import Profile — Maldives (DGFT 2022–2026)

Name: State Trading Organization PLC Pharmaceutical Import Records from India — 5 Products, $461.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

State Trading Organization PLC — Pharmaceutical Importer Profile (2026) | 5 Products, $461.8K Trade | TransData Nexus

State Trading Organization PLC

Pharmaceutical Importer · Maldives · Advanced Oncology Focus · $461.8K Total Trade · DGFT Verified

State Trading Organization PLC is a pharmaceutical importer based in Maldives with a total trade value of $461.8K across 5 products in 4 therapeutic categories. Based on 28 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. State Trading Organization PLC sources from 36 verified Indian suppliers, with Medley Pharmaceuticals Limited accounting for 23.2% of imports.

State Trading Organization PLC — Import Portfolio & Supplier Network

State Trading Organization PLC import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to State Trading Organization PLC?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Medley Pharmaceuticals Limited	$3.6M	595	23.2%
Medix	$2.4M	1,906	15.5%
Dr.reddy's Laboratories Limited	$1.9M

What Formulations Does State Trading Organization PLC Import?

Formulation	Value	Ships
Medicaments - pantaz tabs (Pack of 10	$185.9K	9
Medicaments - vazortan 50MG tabs (Pack	$152.0K	9
Medicaments - atorin 10MG TAB (Pack of	$132.6K	6
Rybelsus 3 MG TAB 10s batch no	$119.5K	7
Mirtazapine - tablets - 15MG - mirtaz 15batch no	$119.5K	3
Fexofenadine hydrochloride -	$116.7K	4
Viropil (90)	$103.6K	3
Viropil (90) batch no: e16jq22003 exp	$103.6K	3
Genotropin 36iu INJ batch no	$103.0K	3
Ujvira 100 MG INJ batch no: g201863	$101.7K	3
Sojourn 250 ML	$100.0K	2
Pharmaceuticals- nasivion adult 10ML	$100.0K	2
Pharmaceuticals- nasivion paed 10ML	$100.0K	2
Lantus solostar 100iu/ML 3ML ( 13000	$100.0K	2
Pharmaceutical products menactra 0.50ML	$100.0K	2

State Trading Organization PLC imports 3,658 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Bevacizumab	Advanced Oncology	$219.2K	10	0.5%	13
2	Diazepam	CNS & Psychiatric	$173.0K	4	2.3%	7
3	Nicotine	Other	$36.1K	5	0.2%	12
4	Nivolumab	Advanced Oncology	$32.3K	6	1.4%	4
5	Soframycin	Brand Names & OTC Products	$1.1K	3	0.2%	7

State Trading Organization PLC imports 5 pharmaceutical products across 4 categories into Maldives totaling $461.8K.

State Trading Organization PLC — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

State Trading Organization PLC (STO) is a state-owned enterprise established in 1964 by the Maldivian government to strengthen national food security. Over the decades, STO has diversified its operations, becoming a leading importer and distributor of essential goods, including pharmaceuticals, medical supplies, fuel, construction materials, and consumer electronics. Headquartered in Malé, the capital of the Maldives, STO plays a pivotal role in the nation's supply chain, ensuring the availability of critical products across the archipelago. (sto.mv)

In the pharmaceutical sector, STO has been instrumental in importing and distributing a wide range of medicines to meet the healthcare needs of the Maldivian population. However, in September 2025, the Maldivian government established the State Pharmaceutical and Medical Supply Corporation Limited (SPMSCL) to exclusively handle the import and distribution of pharmaceuticals, medical consumables, and medical equipment. This strategic move aims to address longstanding challenges related to access to medicines and streamline the supply chain. Consequently, STO's pharmacy operations, encompassing over 190 outlets, were transferred to SPMSCL in early 2026.

2Distribution Network

STO's distribution network is extensive, with operations spanning the entire Maldives. Prior to the transfer of its pharmacy operations to SPMSCL, STO managed over 190 pharmacies nationwide, ensuring widespread access to essential medicines and consumer goods. The company's logistics capabilities include a fleet of vehicles and partnerships with shipping companies to facilitate the timely delivery of products to various islands. While STO's primary focus has been on domestic distribution, it has also engaged in international trade, with operations in Singapore, to source products and manage supply chains effectively. (sto.mv)

3Industry Role

Before the establishment of SPMSCL, STO served as a primary wholesaler and distributor in the Maldivian pharmaceutical supply chain. The company was responsible for importing a diverse range of medicines and medical supplies, which were then distributed through its network of pharmacies and other outlets. This role was crucial in ensuring the availability of essential healthcare products across the Maldives. With the formation of SPMSCL, STO's direct involvement in pharmaceutical distribution has been reduced, allowing SPMSCL to focus exclusively on the importation and distribution of medical supplies.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — State Trading Organization PLC

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

STO's pharmaceutical imports from India have been substantial, with a total import value of $462,000 USD across 28 shipments from 2022 to 2026. The top five products imported include Bevacizumab ($219,000), Diazepam ($173,000), Nicotine ($36,000), Nivolumab ($32,000), and Soframycin ($1,000). These products span therapeutic categories such as Advanced Oncology, CNS & Psychiatric, and Other. The concentration of imports in these specific products indicates a strategic focus on high-demand medications within these therapeutic areas. The absence of a single dominant supplier suggests a diversified sourcing strategy, which can mitigate risks associated with supplier dependency. However, the high concentration in a few products also means that any disruptions in the supply of these items could significantly impact STO's operations.

2Supply Chain Resilience

STO's supply chain resilience is supported by its diversified supplier base, with 36 unique suppliers from India. This broad network helps mitigate risks associated with over-reliance on a single supplier. The company's focus on finished pharmaceutical formulations, rather than raw APIs or bulk drugs, indicates a preference for ready-to-use products, which can streamline distribution and reduce lead times. While the transfer of pharmacy operations to SPMSCL may affect STO's direct involvement in pharmaceutical distribution, the company's established relationships with suppliers and its experience in logistics provide a foundation for continued resilience in the supply chain.

Importing Pharmaceuticals into Maldives — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Maldives

1Regulatory Authority & Framework

The Maldives' pharmaceutical sector is regulated by the Ministry of Health, which oversees the importation, distribution, and sale of medical products. The establishment of SPMSCL in September 2025 centralizes the import and distribution of pharmaceuticals, aiming to streamline operations and improve access to medicines. This move aligns with global best practices, where dedicated entities manage pharmaceutical supply chains to ensure efficiency and accountability.

2Import Licensing & GMP

Import licensing requirements for pharmaceuticals in the Maldives are managed by the Ministry of Health. Suppliers must obtain the necessary approvals to import medical products into the country. The Maldives recognizes Good Manufacturing Practice (GMP) certifications from reputable international bodies, including the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications ensure that imported medicines meet quality standards and are safe for use.

3Quality & Labeling

State Trading Organization PLC — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

STO's focus on importing high-value pharmaceuticals such as Bevacizumab and Diazepam indicates a strategic emphasis on critical and high-demand medications. The concentration in therapeutic areas like Advanced Oncology and CNS & Psychiatric suggests a targeted approach to address prevalent health issues in the Maldives. This strategy aligns with the government's efforts to diversify the range of medicines available, expanding from around 200 to between 800 and 900 items, to strengthen the national healthcare system. (plus.mv)

2Sourcing Profile

STO's sourcing strategy involved importing finished pharmaceutical formulations from a diverse set of suppliers in India. This approach ensured a steady supply of ready-to-use medicines, facilitating efficient distribution. The company's previous role in managing a significant portion of the pharmaceutical supply chain in the Maldives underscores the importance of strategic sourcing in maintaining the availability of essential medicines.

3Market Positioning

Prior to the establishment of SPMSCL, STO served a broad segment of the Maldivian market, including retail pharmacies, hospitals, and government tenders. The company's extensive distribution network and diverse product portfolio enabled it to meet the needs of various healthcare providers and consumers across the nation.

Seller's Guide — How to Become a Supplier to State Trading Organization PLC

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

With the formation of SPMSCL, there is a clear opportunity for new Indian suppliers to engage directly with the government entity responsible for pharmaceutical imports. This shift presents a chance to establish partnerships and supply essential medicines to the Maldivian market. Identifying gaps in SPMSCL's current sourcing and offering competitive, high-quality products can position new suppliers favorably.

2Requirements & Qualifications

Indian exporters aiming to supply pharmaceuticals to the Maldives must ensure their products are registered with the Ministry of Health and comply with the country's import licensing requirements. Obtaining GMP certifications from recognized international bodies such as WHO or PIC/S is essential to meet quality standards. Additionally, adherence to labeling and packaging regulations, including language requirements and serialization mandates, is necessary for market entry.

3How to Approach

Frequently Asked Questions — State Trading Organization PLC

What products does State Trading Organization PLC import from India?

State Trading Organization PLC imports 5 pharmaceutical products across 4 categories. Top imports: Bevacizumab ($219.2K), Diazepam ($173.0K), Nicotine ($36.1K), Nivolumab ($32.3K), Soframycin ($1.1K).

Who supplies pharmaceuticals to State Trading Organization PLC from India?

State Trading Organization PLC sources from 36 verified Indian suppliers. The primary supplier is Medley Pharmaceuticals Limited (23.2% of imports, $3.6M).

What is State Trading Organization PLC's total pharmaceutical import value?

State Trading Organization PLC's total pharmaceutical import value from India is $461.8K, based on 28 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does State Trading Organization PLC focus on?

State Trading Organization PLC imports across 4 categories. The largest: Advanced Oncology (54.5%), CNS & Psychiatric (37.5%), Other (7.8%).

Get Full State Trading Organization PLC Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.